The contract renewal will see Epichem continue to provide its synthetic and medicinal chemistryexpertise to support DNDi’s drug discovery projects, aimed at developing new treatments for neglecteddiseases, until 31st December 2021. The extension is expected to generate up to AUD$1.02M inrevenues for Epichem during CY 2021.
Ann: Epichem Awarded Contract Extension from DNDi, page-3
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $92.46M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 18.5¢ | $177.2K | 929.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 499621 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 70000 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |